Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Meet the Innovators of the Year for Senior Health honorees for Atlanta Business Chronicle's Health Care Champion Awards.

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health jumped 3.1% in the last session, extending its six-day rally. The surge was fueled by investor optimism, a ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Elevance Health received a consensus analyst rating of "Moderate Buy," indicating confidence in the company's potential. Out ...

Health insurance companies appear to be denying a growing share of patient claims. Why?

Rising Dividend Fund A Shares (without sales charge*) posted a return of -5.60% in fourth quarter 2024. Read more here.

Wall Street expected President Donald Trump to go easier on Medicare Advantage insurers than his predecessor. That's not ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...